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ABSTRACT
Introduction Falls in hospitals and care homes are 
a major issue of international concern. Inpatient falls 
are the most commonly reported safety incident in the 
UK’s National Health Service (NHS), costing the NHS 
£630 million a year. Injurious falls are particularly life- 
limiting and costly. There is a growing body of evidence 
on shock- absorbing flooring for fall- related injury 
prevention; however, no systematic review exists to 
inform practice.
Methods and analysis We will systematically identify, 
appraise and summarise studies investigating the clinical 
and cost- effectiveness, and experiences of shock- 
absorbing flooring in hospitals and care homes. Our search 
will build on an extensive search conducted by a scoping 
review (inception to May 2016). We will search electronic 
databases (AgeLine, CINAHL, MEDLINE, NHS Economic 
Evaluation Database, Scopus and Web of Science; May 
2016–present), trial registries and grey literature. We 
will conduct backward and forward citation searches of 
included studies, and liaise with study researchers. We 
will evaluate the influence of floors on fall- related injuries, 
falls and staff work- related injuries through randomised 
and non- randomised studies, consider economic and 
qualitative evidence, and implementation factors. We will 
consider risk of bias, assess heterogeneity and explore 
potential effect modifiers via subgroup analyses and 
sensitivity analyses. Where appropriate we will combine 
studies through meta- analysis. We will use the GRADE 
(Grading of Recommendations, Assessment, Development 
and Evaluations) approach to evaluate the quality of 
evidence and present the results using summary of 
findings tables, and adhere to the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses reporting 
guidelines.
Ethics and dissemination We will follow the ethical 
principles of systematic review conduct, by attending 
to publication ethics, transparency and rigour. Our 
dissemination plan includes peer- reviewed publication, 
presentations, press release, stakeholder symposium, 
patient video and targeted knowledge- to- action reports. 
This review will inform decision- making around falls 
management in care settings and identify important 
directions for future research.
PROSPERO registration number CRD42019118834.
InTROduCTIOn
Falls in health and social care settings are 
a major concern for older adults globally, 
causing morbidity, mortality and economic 
burden.1–3 Falls have been climbing the 
league tables of the leading causes of global 
disability- adjusted life years,4 with falls and 
injury rates in residential care settings substan-
tially higher than that of older people living in 
the community.1 In the UK, inpatient falls are 
the most commonly reported safety incident 
with over 250 000 reported per year in the 
National Health Service (NHS) in England 
alone.5 Falls have a complex aetiology of 
Strengths and limitations of this study
 ► This will be a mixed methods systematic review 
including randomised and non- randomised clinical 
studies, economic and qualitative evidence.
 ► Studies will be assessed using the updated 
Cochrane risk of bias tools for quantitative evidence, 
and Joanna Briggs Institute method for qualitative 
studies.
 ► Analyses will be at the study level, which limits the 
scope for exploring moderating factors related to 
patient- level characteristics on the effectiveness of 
flooring interventions.
 ► The quality of the evidence will be summarised us-
ing the GRADE approach, with the strength of the 
review’s findings limited to the quantity and internal 
validity of the included studies.
 ► We will be guided by the Knowledge- to- Action 
Framework to facilitate the translation of the find-
ings into practice.
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intrinsic (eg, co- morbidities, cognitive function, mobility) 
and extrinsic (eg, environmental design, staffing, foot-
wear, medication) risk factors3 6–8 and no single solu-
tion effectively prevents them. A systematic review of 
falls prevention interventions in institutional settings,9 
found low quality evidence, with uncertain conclusions 
for a range of interventions including: exercise, physio-
therapy, sensor alarms and multifactorial interventions. 
This review excluded studies targeting fall- related injury 
prevention, yet the prevention of severe falls is consid-
ered a priority.5 One of the most severe consequences of 
falls are hip fractures, but wearable hip protectors have 
poor compliance which is a barrier to their use.10 Unlike 
hip protectors, manipulating the physical environment is 
a promising intervention for reducing injurious falls as 
it requires no compliance from patients or staff, and can 
accommodate other injury types.
Shock- absorbing flooring can reduce the impact forces 
of falls by decreasing the stiffness of the ground surface.11 
However, softer floors could negatively impact on gait, 
potentially leading to increased falls risk.11–15 The poten-
tial benefits and risks of shock- absorbing floors may vary 
depending on the type of patient utilising them. Further-
more, adverse effects of shock- absorbing floors may 
present in staff if greater effort is required to manoeuvre 
rolling equipment, potentially increasing injury risk.16
There has been no comprehensive systematic review 
focusing on flooring interventions in healthcare settings 
for fall- related injury prevention. A recent scoping review 
of flooring interventions involved a thorough search 
of the literature; however, it did not involve a critical 
appraisal or systematic synthesis.17 A systematic review 
of studies identified in the scoping review16 18–25 as well 
as more recent studies,26–31 will provide a more reliable 
basis for decision- making and identify the next steps for 
research.
This publication is an abridged version of the full 
protocol,32 and is registered on PROSPERO.33 Any 
important protocol amendments will be published on 
these platforms.32 33 We have conformed to the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
Protocols (PRISMA- P)34 in the writing of this protocol 
(online supplementary file 1).
Aims and objectives
We aim to systematically review the evidence on shock- 
absorbing flooring use in care settings (hospitals and care 
homes) for fall- related injury prevention in older adults. 
Specifically, we will:
1. Assess the potential benefits (fall- related injury preven-
tion) and risks (falls; staff injuries) of different flooring 
systems in care settings.
2. Assess the extent to which these potential benefits and 
risks may be modified by different study/setting, inter-
vention and participant characteristics.
3. Critically appraise and summarise current evidence on 
the resource use, costs and cost- effectiveness of shock- 
absorbing flooring in care settings for older adults, 
compared with standard flooring.
4. Summarise findings on the implementation of floor-
ing interventions in the included studies.
5. Summarise the views and experiences of shock- 
absorbing flooring use from staff, patients’/residents’ 
and visitors’ perspectives.
6. Identify gaps in existing evidence.
METhOdS
Eligibility criteria
Population
The target population for the intervention to potentially 
benefit is older adults in care settings. We have no set 
cut- off criteria for age, as chronological age may not be 
a good indicator of frailty.35 Studies must focus on adult 
populations to be included; studies focusing solely on 
children will be excluded. We are also interested in staff 
outcomes.
Setting
Studies must have been conducted in a care setting 
(defined below) including hospitals (acute, sub- acute), 
intermediate and long- term care settings (nursing and 
care homes). Studies conducted in people’s own homes, 
or other settings (eg, playgrounds, sporting venues) will 
be excluded.
Care settings will be broadly defined as36:
 ► Care home environments (a facility that provides: 
communal living facilities for long- term care; over-
night accommodation; nursing or personal care; for 
people with illness, disability or dependence).
 ► Hospital environments (a facility that provides: 
communal care where there is an expectation that 
this care is time limited; overnight accommodation; 
nursing and personal care for people with illness and 
disability).
Interventions
Interventions may include flooring systems which have 
been purposely designed to prevent fall- related injuries 
(eg, SmartCells, Sorbashock, Kradal), thick vinyl (>5 mm 
thick; eg, sports floors, such as Tarkett Omnisports Excel), 
carpet with or without underlay, and other combination 
flooring systems (eg, vinyl overlays with padded underlays, 
such as foam or rubber, or wooden subfloors). Alternative 
terminology for the intervention may include variations 
on the terms: compliant flooring, safety flooring, soft 
flooring, impact absorbing flooring, energy absorbing 
flooring, low- impact flooring, dual stiffness flooring, low 
stiffness flooring, absorptive surfaces, cushioned flooring, 
rubber flooring, acoustic flooring and carpet.
We will exclude studies reporting exclusively on mats 
as they are not permanently affixed to the floor and do 
not provide universal coverage or protection; mats have 
different implications for installation and practice and 
are not the focus of this review. Studies in which flooring 
is one component of a package of interventions and the 
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effects of the floor cannot be distinguished from concur-
rent interventions will be excluded.
Comparator
Our main control group is standard or rigid flooring (eg, 
concrete subfloor,≤2 mm vinyl/resilient flooring). We will 
include head- to- head comparisons of different types of 
shock- absorbing flooring systems where possible. Studies 
may compare any combination of flooring systems 
(subfloors and overlays).
Outcomes
The reporting of specific outcomes does not form part 
of our eligibility criteria for studies to be included in this 
review.
Study design
We will include randomised, non- randomised, obser-
vational, economic and qualitative studies. While 
randomised trials of flooring are feasible, the nature 
and logistics of the intervention make observational and 
opportunistic quasi- experimental designs more practical. 
Studies will be classified according to their component 
design features using the study design features presented 
in the Cochrane Handbook.37 The following study designs 
will be eligible:
 ► Individually or cluster randomised controlled trials.
 ► Quasi experimental studies where allocation is 
non- random.
 ► Interrupted times series.
 ► Controlled before and after studies.
 ► Cohort studies.
 ► Case- control studies.
 ► Partial and full economic evaluations, based on a 
single study or model.
 ► Qualitative studies to explore experiences, attitudes 
and perceptions towards flooring interventions.
We will exclude simple before and after studies meas-
uring quantitative outcomes, with no evaluation of time 
trends or concurrent control.
Information sources and search strategy
To avoid duplication of effort, we will build on the search 
already conducted in a scoping review17 which completed 
its search in May 2016. The clinical12 16 18–26 38–46 and 
cost- effectiveness11 21 26 40 41 47–63 records identified in 
the scoping review will be assessed for inclusion in the 
current review. We will continue the search from May 
2016 to present, and will not apply any language restric-
tions. A comprehensive search, as listed in table 1, will 
be undertaken, to include electronic databases, grey 
literature, hand searches, citation screening and expert 
consultation.
We have adapted the broader search strategy of the 
scoping review17 to make it more specific to the current 
study (The SAFEST Review). The strategy for MEDLINE 
(online supplementary file 2) is based on our eligibility 
criteria and uses a combination of keyword synonyms and 
controlled vocabulary terms (eg, MeSH). We will adapt 
the MEDLINE search for other information sources.
Study records
Data management
We will import the search records into EndNote online 
and use Covidence54 to support duplicate record iden-
tification, screening, data collection and risk of bias 
assessment processes, identification and resolution of 
discrepancies, and producing a PRISMA flow diagram.55 
Data analyses will be undertaken in RevMan,56 and 
summary of findings (SoF) tables and Evidence Profiles 
will be created using GRADE Pro.57 58
Selection process
We will screen titles, abstracts and full reports inde-
pendently in duplicate using an eligibility checklist. All 
records included in the clinical and cost- effectiveness 
sections of the scoping review will be assessed at the full 
report stage. From the results of the updated search, we 
will begin by screening titles, and those that look poten-
tially relevant will be reviewed in abstract form. We will 
then screen the full texts of records that appear defi-
nitely or possibly relevant. Discrepancies will be resolved 
through a third independent arbitrator.
Data collection process
Our theoretical framework of potential effect modifiers 
(figure 1) will underpin the data collection process. We 
will develop and pilot the data collection form with a 
data collection manual. Two reviewers will independently 
undertake data collection and assessment of risk of bias.
Data collection will include the following key compo-
nents of information:
 ► Study identification.
 ► Time/duration and geographical place of conduct.
 ► Participant characteristics.
 ► Intervention(s).
 ► Control(s).
 ► Outcome data acquisition: method of falls reporting; 
classification system of injuries; identification of frac-
tures (confirmation of diagnosis/type of fractures 
included); identification of adverse effects.
 ► Setting.
 ► Study design.
 ► Risk of bias.
 ► Outcomes data.
 ► Patient and public involvement in the research.
 ► Follow- up questions for study authors.
Outcomes and prioritisation
There is no core outcome set specifically for flooring 
interventions; however we have considered the common 
outcome data set for fall injury prevention trials in 
community- dwelling populations59 and the international 
consensus statement for trials on hip protectors.60 Recog-
nising the unique features of our review and through 
stakeholder engagement61 and discussion with our public 
 o
n
 February 19, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032315 on 17 February 2020. Downloaded from 
4 Drahota A, et al. BMJ Open 2020;10:e032315. doi:10.1136/bmjopen-2019-032315
Open access 
Table 1 List of information sources
Search type Information sources
Electronic databases AgeLine (EBSCO)
CINAHL Complete (EBSCO)
MEDLINE (EBSCO)
NHS Economic Evaluation Database (Centre for Reviews and Dissemination)
Scopus
Web of Science (Thomson Reuters)
Grey literature search Clinical trial registries
WHO International Clinical Trials Registry Platform
Theses/dissertations
ProQuest Theses and Dissertations
Abstracts/conference proceedings
Biennial Conference of the Australian and New Zealand Falls Prevention Society
Canadian Association on Gerontology Annual Scientific and Educational Meeting Gerontological 
Society of America's Annual Scientific Meeting
International Society for Posture and Gait Research World Congress
World Conference of Gerontechnology
World Congress of the International Association of Gerontology and Geriatrics
Websites
Agency for Healthcare Research and Quality
Canadian Agency for Drugs and Technologies in Health
NHS Improvement
NICE Guidelines
Open Grey (opengrey.eu)
Parachute Canada
The National Institute for Occupational Safety and Health
The International Network of Agencies for Health Technology Assessment
UK Health Technology Assessment
US Center for Health Design
WHO Health Evidence Database
Hand searching and 
citation screening
Reference lists
References of included studies
Forward citation searching of included studies in Web of Science
Journal
Age and Ageing
NHS, National Health Service; NICE, National Institute for Health and Care Excellence.
involvement group, we have prioritised the following 
outcome measures:
Primary outcomes:
 ► Injurious falls rate per 1000 person- bed days.
 ► Falls rate per 1000 person- bed days.
These measures assess the potential benefits and 
harms of flooring interventions for patients/residents, 
accounting for bed occupancy levels and follow- up time; 
injurious falls rate additionally accounts for variations 
to the underlying falls rate, as a pragmatic measure of 
effectiveness.
Secondary outcomes:
 ► Number of falls with injuries (eg, none, minor, 
moderate, severe, death).
 ► Number of fractures.
 ► Number of hip fractures.
 ► Number of fallers (risk of falling ≥1 times).
 ► Number of adverse events (eg, staff injuries as defined 
by study authors).
 ► Number of head injuries.
 ► Fractures per 1000 patient- bed days.
 ► Hip fractures per 1000 patient- bed days.
 ► Qualitative outcomes (eg, attitudes, views, and experi-
ences of staff, patients/residents, visitors).
 ► Economic outcomes (to include assessments of 
quality- adjusted life years).
 ► Process outcomes (eg, ease of, or problems with, 
flooring installation).
Risk of bias in individual studies
Risk of bias assessment will be undertaken using the 
updated Cochrane risk of bias tool (ROB 2.0) for 
randomised trials62 and the Risk Of Bias In Non- 
randomised Studies of Interventions (ROBINS- I) tool63 
for other quantitative designs. We will assess the risk of 
bias at the level of study results. Review authors will not be 
blinded during risk of bias assessments; however, where 
they have been involved in co- authoring an included 
study, assessments will be undertaken by at least two other 
independent reviewers. Supporting information and 
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Figure 1 Theoretical framework of potential effect modifiers.
justification for judgements (high, low, some concerns) 
will be recorded for each bias domain. We will follow 
the guidance to derive summary judgements for each 
outcome, which will be used to inform our sensitivity anal-
yses and GRADE assessments.57
data analysis (quantitative studies)
Dealing with missing data
We will seek further information from study authors 
where required. If missing data are from participant/
cluster dropouts, analyses will be based on the available 
data and an assessment of the problem will be included 
as part of our risk of bias judgements.
Measures of treatment effect
We will report rates of injurious falls, falls and fractures 
using incidence rate ratios and 95% CI. We will use risk 
ratios (95% CI) to describe number of fallers, number of 
falls with fall- related injuries and number of participants 
with fall- related fractures or head injuries. Where avail-
able we will also report hazard ratios for falls including all 
falls from recurrent fallers. For non- randomised studies, 
we will record the unadjusted and adjusted estimates and 
note the factors adjusted for. Where multiple adjusted 
estimates are presented, we will extract the estimate high-
lighted as the primary model by the authors, or where 
this is unclear, take the model which has adjusted for the 
most covariates. Where rate ratios or risk ratios are not 
reported, we will calculate them where feasible.37
Where studies present a break- down of the severity 
of injuries (as ordinal outcome data, eg, none, mild, 
moderate, severe, death), we will present these descrip-
tively, and if studies have used similar categorisation 
systems, using figures where feasible. We will report 
adverse events to staff as a risk or rate ratio (per 100 
working staff- days) where possible, or as the number of 
events observed during the follow- up period, if no clear 
denominator is known.
Unit of analysis issues
To avoid the issue of double counting, we will link multiple 
associated publications together. When primary studies 
include multiple study arms, we will either combine the 
groups (if logical) or include only one pair- wise compar-
ison (intervention vs control) in any one analysis. In the 
case of cluster randomised trials we will take clustering 
into account, and plan to adjust the estimates using an 
intra- cluster correlation coefficient (ICC) borrowed from 
another similar study if required.37
Assessment of reporting bias
Where possible, we will produce funnel plots with 
different plotting symbols to identify subgroups. Funnel 
plot asymmetry will be tested if there are sufficient data 
(at least 10 studies to be combined), and visual inspection 
of the plots will be used to interpret the findings.
Data synthesis
Should meta- analysis be viable, studies will be combined 
using a random- effects model, assuming that interven-
tion effects are likely to vary across studies (figure 1). We 
will use the generic inverse variance data type to produce 
forest plots in RevMan56; this method requires entering 
the natural logarithm of the rate ratio or risk ratio and its 
SE for each study. We will use 95% CIs throughout. Where 
evidence exists from randomised and non- randomised 
studies, we will report the data separately, giving more 
emphasis to the findings from randomised trials. We 
will organise non- randomised studies according to 
whether data collection was prospective or retrospective, 
and if controls were concurrent or historical. If appro-
priate, we will combine the data from randomised and 
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non- randomised studies to provide an overall summary 
effect estimate.
Assessment of heterogeneity
Heterogeneity will be explored irrespective of whether 
we decide to pool studies in a meta- analysis. Heteroge-
neity will be assessed through a combination of visual 
inspection of the forest plots, along with consideration 
of tests for homogeneity (χ² with statistical significance 
set at p<0.10), and measures for inconsistency (I²) and 
heterogeneity (tau2).
Where feasible, we plan to undertake subgroup analysis 
based on:
 ► Study design (randomised, non- randomised).
 ► Study setting (hospital, care home).
 ► Acuity of care (acute, sub- acute, intermediate, long- 
term care).
 ► Flooring type (novel shock- absorbing flooring, thick 
vinyl/vinyl & underlay, carpet, wooden subfloor).
Sensitivity analyses
Sensitivity analyses will be undertaken based on:
 ► Risk of bias (eg, removing studies at high risk of bias 
on the ROB 2.0 tool, or critical/serious risk of bias on 
the ROBINS- I tool).
 ► Choice of effect estimates (eg, where multiple adjusted 
estimates are reported, the analysis will be run on the 
most optimistic and pessimistic scenarios).
 ► Adjustment for clustering where an ICC has been 
borrowed from another study (eg, we will assess 
the impact of opting for more or less conservative 
adjustments).
Synthesis of qualitative studies
A meta- aggregative approach will be used to synthesise 
data from qualitative studies.64 We will derive generalis-
able statements, in the form of recommendations that 
can be used to guide end- users of the review (eg, NHS 
chief executives, care home managers, estates/facilities 
managers, healthcare designers and builders, health and 
social care professionals, patients, residents and carers). 
Studies will be critically assessed using the Joanna Briggs 
Institute’s critical appraisal tool.64 We will follow the data 
collection process as above, and use QSR NVivo software 
for data analysis.65
Synthesis of economic evidence
We will align our approach for the incorporation of costs 
data to an exemplar systematic review by Garrison and 
colleagues.66 One reviewer (LF) will extract all data from 
included economic evaluations, which will be checked by 
an expert reviewer (JR). Our data extraction form will be 
based on the format and guidelines used to produce struc-
tured abstracts of full economic evaluations for inclusion 
in the NHS Economic Evaluation Database. The method-
ological quality of included economic evaluations will be 
assessed through the use of recognised checklists based 
on guidelines for economic submissions to the British 
Medical Journal (for economic evaluations based on a 
single study),67 and for quality assessment in economic 
decision- analytic models (for model- based economic eval-
uations).68 Data extraction will include study character-
istics such as country, settings, aims and methodological 
aspects related to economic evaluation, individual items 
within the respective checklists,67 68 and the economic 
variables. We will collect the following economic vari-
ables, if reported: costs of flooring (purchasing, installa-
tion, maintenance); costs of falls based on injury, such as 
hospital resources (eg, increased length of stay, additional 
surgery needs), and post- discharge healthcare cost (eg, 
hospital readmission, outpatient visits); utility measures 
such as quality of life, life years and quality adjusted life 
years; and summary measures such as incremental cost- 
effectiveness ratio, net monetary benefits and value of 
information.
We will classify economic evaluations by type (Partial 
evaluations: ‘outcome description’, ‘cost description’, 
‘cost- outcome description’, ‘efficacy or effectiveness 
evaluation’ or ‘cost- analysis’; Full economic evaluations: 
‘cost- effectiveness analysis’, ‘cost- utility analysis’ or ‘cost- 
benefit analysis’) and as either an economic evaluation 
based on a single study or a model- based economic eval-
uation. Where necessary, additional information from 
study authors will be sought.
Results will be tabulated and summarised narratively in 
the text. We will adjust all costs to 2019 pound sterling 
values using gross domestic product deflators, and use 
relevant exchange rates for international comparisons.
Confidence in cumulative evidence
Quantitative evidence
The quality of evidence will be assessed across the 
included studies at outcome level for each comparison 
using GRADE,57 and incorporated into SoF tables using 
the GRADEpro software.58 Our main comparison will be 
‘shock- absorbing flooring vs standard flooring’, and we 
will include separate SoF tables for hospitals and care 
homes. Supplementary SoF tables will be developed for 
different types of shock- absorbing floors versus standard 
flooring, and for head- to- head comparisons of different 
shock- absorbing flooring interventions.
The following outcomes will be included: (1) injurious 
falls rate per 1000 patient- bed days; (2) falls rate per 
1000 patient- bed days; (3) number of falls with injuries 
(eg, none, minor, moderate, severe); (4) number of frac-
tures; (5) number of hip fractures; (6) number of fallers; 
and (7) number of adverse events related to staff inju-
ries. We will create supporting ‘Evidence profile’ table.57 
The GRADE system provides a grade of the overall quality 
of the evidence for each outcome on one of four levels: 
high, moderate, low, very low.
Qualitative evidence
The CERQual group’s recommendations will be followed 
to assess the quality of qualitative evidence included in 
the review.69 Each review finding will be assessed based 
on methodological limitations, coherence, adequacy of 
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data and relevance.70 We will make an overall assessment 
of confidence for each review finding on one of the four 
levels: high, moderate, low, very low. Assessments will be 
presented in ‘CERQual Evidence profile’, and ‘Summary 
of Qualitative Findings (SoQF)’ tables.
EngAgEMEnT wITh STAkEhOldERS
We will consult with key stakeholders and a range of 
potential knowledge users during our review. Our Advi-
sory Board includes the following knowledge users: Falls 
in older people National Institute for Health and Care 
Excellence Guideline Developer; Safety and Improve-
ment Clinical Lead (Leeds Teaching Hospitals NHS 
Trust); director/chairman of the Health Estates and 
Facilities Management Association; chairman of the 
National Care Association; public members; and shock- 
absorbing flooring researchers from health sciences and 
engineering disciplines in the UK and Canada. Collec-
tively, members of the board possess the relevant exper-
tise and decision- making authority to critically evaluate 
and implement shock- absorbing flooring systems in high- 
risk environments such as hospitals and long- term care 
in the UK, and use systematic review evidence to inform 
future research.
An interactive process of communication between 
researchers and the Advisory Board will be used 
throughout the review process. We will involve the Board 
in a number of important ways1: in providing input on the 
design and implementation of the review2; as members of 
the project team who attend project meetings and inform 
us of emerging primary research evidence3; in the inter-
pretation of findings and identification of research gaps; 
and4 in the packaging and dissemination of the review’s 
findings in a form that is relevant, practical and easily 
interpreted by other decision- makers and knowledge 
users.
PATIEnT And PuBlIC InvOlvEMEnT
Three public members engaged actively in the prepara-
tion of our funding proposal. They informed our deci-
sions relating to methodology, particularly prioritising 
outcomes, confirming settings and development of the 
theoretical framework.
The public members will participate in five specific 
patient and public involvement meetings over the course 
of the project. Each meeting will include a brief training 
session to explain the stage of the review the project is at, 
and the processes and tasks involved. They will contribute 
to the conduct of the systematic review in the following 
ways: (1) commenting on the clarity and comprehensive-
ness of the protocol; providing an independent judge-
ment as to the fairness, transparency and consistency of 
(2) the risk of bias and (3) GRADE judgements made by 
the project team; (4) providing feedback on the clarity 
of information presented in the SoF tables, as well as the 
order and presentation of comparisons and subgroups; 
and (5) providing feedback on the clarity, comprehensive-
ness and presentation of the project outputs (including 
the plain English summary).
EThICS And dISSEMInATIOn
We do not need to obtain ethical review, as this is an 
evidence synthesis. Nonetheless, our ethical consider-
ations71 will relate to: (1) appropriateness of authorship 
on the final works; (2) avoidance of duplication in the 
publication of the findings; (3) avoiding plagiarism by 
ensuring that all reported findings are sufficiently cited 
and attributable to the source material; (4) transpar-
ency, in the form of acknowledging all contributions and 
competing interests; (5) having due rigour in the data 
collection and reporting phases of the review to ensure 
the accuracy of the findings; and (6) flagging suspected 
fraudulent or plagiarised research to the publishing 
journals.
Our research approach is underpinned by the Knowl-
edge to Action Framework,72 and will ensure involvement 
of knowledge users with researchers throughout the 
process.
We will disseminate our research outputs using the 
following media:
 ► Open access peer- reviewed journal publication.
 ► Presentations at national and international confer-
ences, and a webinar.
 ► Press release/social media with an item in relevant 
media outlets (eg, The Conversation; The Health 
Estates and Facilities Management Association 
‘HEFMA Pulse’ magazine).
 ► A half- day stakeholder symposium, the outputs of 
which will be made available online.
 ► A short video distilling the review findings via patient 
stories.
 ► Knowledge to Action Reports tailored to NHS chief 
executives, care home managers and estates/facilities 
managers, healthcare designers and builders.
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